# Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by Surgery

> **NCT00459121** · PHASE2 · TERMINATED · sponsor: **Barbara Ann Karmanos Cancer Institute** · enrollment: 2 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** paclitaxel
- **DRUG:** Zactima
- **PROCEDURE:** neoadjuvant therapy

## Key facts

- **NCT ID:** NCT00459121
- **Lead sponsor:** Barbara Ann Karmanos Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-07
- **Primary completion:** 2008-01
- **Final completion:** 2008-10
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2019-03-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00459121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00459121, "Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by Surgery". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00459121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*